Saturday, September 27, 2025

Moon Surgical Gets FDA Clearance for Maestro, ScoPilot AI Tools

Related stories

Aisles Launches DREAM: AI-Driven Virtual Reality Evolution

Aisles has unveiled DREAM (Dynamic Reality Experience and Memory),...

TechSee Unveils Visual Remote Assistance with AI (VRAi) on Salesforce

TechSee, a global leader in visual customer assistance, announced...

Rendever and Lenovo Collaborate to Bring Virtual Reality Experiences to Carolina Caring Seniors

Rendever, the Boston-based company pioneering the future of aging...

Ansys 2024 R1 Reimagines the User Experience while Expanding Multiphysics Superiority Boosted by AI

The latest release from Ansys, 2024 R1, introduces an elevated user...

eXeX and Neurosurgeon Dr. Robert Masson Achieve World First Using Apple Vision Pro

eXeX™, a leader in artificial intelligence and mixed reality...
spot_imgspot_img

Moon Surgical, announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two major advancements to its Maestro System: connectivity of the platform to power the Maestro Insights product and a Predetermined Change Control Plan (PCCP) to evolve its AI-powered ScoPilot product.

With this clearance, Maestro Systems can now have active Wi-Fi and 5G connectivity, enabling seamless data exchange with Maestro Insights—Moon’s cloud-based platform that gives surgical teams and administrators access to actionable insights from procedural data. Through Maestro Insights™, users can track utilization, monitor progress toward individual and facility-wide goals, and manage scheduling and optimize resources and workflows across sites.

“Connectivity unlocks a new layer of value for our customers,” said Anne Osdoit, CEO of Moon Surgical. “With Maestro Insights, surgical teams gain a clearer understanding of their practice, and hospitals gain the tools to better manage and scale their surgical services. It’s the next step in making data-driven surgery a practical reality.”

Also Read: ValGenesis & CAI Partner on AI Digital Validation in Pharma

Concomitantly, the FDA also cleared a Predetermined Change Control Plan (PCCP) for ScoPilot, the first Physical AI application integrated into the Maestro platform. ScoPilot enables seamless laparoscope control through real-time movement of the surgeon’s instruments. The PCCP allows Moon to build, test, and safely deploy evolving versions of ScoPilot more efficiently.

“The PCCP clearance marks a pivotal moment for Physical AI,” said Jeff Alvarez, Chief Strategy Officer at Moon Surgical. “It opens the door to an entirely new pace of innovation; allowing us to continuously expand what ScoPilot can do and accelerate how Maestro elevates surgical teams in the OR.”

This dual clearance marks an important inflection point in the expansion of Maestro’s capabilities, underscoring Moon Surgical‘s commitment to building the operating room of the future; one that is more efficient, sustainable, and digitalized.

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img